Breaking News
Investing Pro 0
Free Webinar - Crude Oil Trading 2023 | Thursday, February 9, 2023 | 01:00PM PST Enroll Now

Amdocs' (DOX) Q1 Earnings and Revenues Surpass Estimates

By Zacks Investment ResearchStock MarketsFeb 01, 2022 11:30PM ET
www.investing.com/analysis/amdocs-dox-q1-earnings-and-revenues-surpass-estimates-200616829
Amdocs' (DOX) Q1 Earnings and Revenues Surpass Estimates
By Zacks Investment Research   |  Feb 01, 2022 11:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
AAPL
-1.75%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ADI
-1.80%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ACLS
-0.98%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DOX
+0.02%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Amdocs (NASDAQ:DOX) Limited DOX reported first-quarter fiscal 2022 non-GAAP earnings of $1.20 per share, which increased 3.4% from the year-ago quarter and surpassed the Zacks Consensus Estimate of $1.19. The bottom line was higher than the mid-point of the guided range of $1.15-$1.21.

Record revenues of $1.11 billion beat the consensus mark of $1.10 billion and came above the mid-point of the guided range of $1.08-$1.12 billion. Compared with the year-ago quarter, revenues were up 1.7% on a reported basis and 10.6% on a constant currency basis.

Amdocs’ top-line performance was primarily driven by North America’s high activity levels among top consumers. However, foreign currency movements subdued the figure.

Amdocs Limited Price, Consensus and EPS Surprise

Quarterly Details

North America reported record revenues of $745 million (67.5% of total revenues), indicating a 6% year-over-year surge.

Europe revenues (12.9% of total revenues) of $143 million slumped 17%, year over year. Rest of the World revenues (19.6% of total revenues) grew 2.5% year over year to $217 million.

Managed services revenues jumped 5.8% year over year to $660 million.

The company ended fiscal first-quarter 2022 with a 12-month backlog of $3.83 billion, up $140 million sequentially and 9.7%, year on year.

Non-GAAP research & development expenses, as a percentage of revenues, expanded 40 basis points (bps) on a year-over-year basis to 7.3%.

Non-GAAP selling, general & administrative expenses, as a percentage of revenues, increased 20 bps year over year to 10.8%.

Non-GAAP operating margin expanded 20 bps to 17.5%.

Balance Sheet and Cash Flow

Amdocs had cash and short-term investments of $868.8 million as of Dec 31, 2021, compared with $965.6 million as of Sep 30, 2021.

Net cash provided by operating activities was $204 million, up from $199.7 million in the previous quarter and down from $416.5 million in the year-ago period. Free cash flow was $146.9 million compared with the previous quarter’s $138.8 million and the year-earlier quarter’s $366.4 million.

During the fiscal first quarter, the company repurchased shares worth $171 million. Amdocs’ board approved the new increased quarterly cash dividend rate of 39.5 cents per share. The dividends will be paid out on Apr 29, 2022 to the shareholders of record as of Mar 31, as approved in the annual general meeting held in January.

Guidance Update

For fiscal 2022, Amdocs now anticipates revenue growth of 3.4-7.4% on a reported basis, compared with the previous forecast of 3.7-7.7%. On a constant currency basis, revenues are projected to increase in the band of 6-10% year over year, in line with the earlier projection.

The updated fiscal 2022 outlook reflects an expected unfavorable foreign-currency impact of approximately 0.6% on a year-over-year basis compared with the previous forecast of 0.3%.

Adjusted earnings are still estimated to grow between 6.3% and 10.3%.

For the second quarter of fiscal 2022, the company projects revenues between $1,110 million and $1,150 million and adjusted earnings in the range of $1.22-$1.28 per share. The outlook reflects an expected unfavorable foreign-currency impact of approximately $2 million.

Zacks Rank & Key Picks

Amdocs currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks from the broader computer and technology sector include the iPhone maker Apple AAPL, sporting a Zacks Rank #1 (Strong Buy), Analog Devices (NASDAQ:ADI) ADI and Axcelis Technologies (NASDAQ:ACLS) ACLS, both carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Apple’s second-quarter fiscal 2022 earnings has been revised upward by 3.6% to $1.43 per share over the past seven days. For fiscal 2022, earnings estimates have moved upward by 5.9% to $6.15 per share in the past seven days.

Apple’s earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 20.3%. AAPL stock has appreciated 30.4% in the past year.

The Zacks Consensus Estimate for Analog Devices’ first-quarter fiscal 2022 earnings has been revised downward by a penny to $1.68 per share over the past 30 days. For fiscal 2022, earnings estimates have moved north by 7 cents to $7.53 per share in the past 30 days.

Analog Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 6.1%. Shares of ADI have increased 12.1% in the past year.

The Zacks Consensus Estimate for Axcelis Technologies fourth-quarter 2021 earnings has been revised upward by 16 cents to 84 cents per share over the past 90 days. For 2021, earnings estimates have moved north by 8.5% to $2.67 per share in the last 90 days.

Axcelis’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 24.2%. Shares of ACLS have rallied 75.2% in the past year.


Just Released: Zacks' 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +25.3% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Analog Devices, Inc. (ADI): Free Stock Analysis Report

Apple Inc. (NASDAQ:AAPL): Free Stock Analysis Report

Amdocs Limited (DOX): Free Stock Analysis Report

Axcelis Technologies, Inc. (ACLS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Amdocs' (DOX) Q1 Earnings and Revenues Surpass Estimates
 

Related Articles

Amdocs' (DOX) Q1 Earnings and Revenues Surpass Estimates

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email